Hims & Hers Health, Inc. (HIMS) — Analysis Summary
Hims & Hers Health, Inc. (HIMS) has a market cap of $7.39B with year-over-year revenue growth of +59.0%. Net margin stands at 5.5%. The stock trades at a P/E ratio of -52.0.
Key Takeaways
- Revenue changed +59.0% year-over-year
- Net margin of 5.5%
- P/E ratio of -52.0
Compared to other companies in the SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE sector, HIMS posted revenue growth of +59.0% and trades at a P/E of -52.0.
Hims & Hers Health, Inc. (HIMS)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Net income turned negative after a profitable prior period.
Current ratio at 0.93x — current liabilities exceed current assets
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
Sector
SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE
Employees
2,442
Headquarters
SAN FRANCISCO, CA
Exchange
XNYS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.